We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Hormone Replacement Therapy Causes No Excess Cardiovascular Risk

By HospiMedica staff writers
Posted on 21 Jan 2008
A new study shows that hormone replacement therapy (HRT) in women in early menopause may have no increased cardiovascular risk from the therapy, but could even show future benefit. More...


Researchers of the American Association of Clinical Endocrinologists (AACE, Jacksonville, FL, USA) conducted a meta-analysis of 23 trials that compared results of HRT in women younger than 60, or less than 10 years since menopause. Studies included the Women's Health Initiative (WHI), The Heart and Estrogen-Progestin Replacement Study (HERS), and the Postmenopausal Estrogen-Progestin Interventions study (PEPI). The study results showed that when re-evaluating the studies to permit an analysis of cardiovascular disease based on age, the studies showed that after a three-year period, there was no difference in the incidence of cardiovascular disease between the HRT group and the placebo group. The study results were issued in a press release by the AACE on January 2, 2008.

"We think the data offer some reassurance to women close to the menopause, with the suggestion that estrogen supplementation may even protect against heart disease in these younger women,” said co-author Rhoda Cobin, M.D., of the Mount Sinai School of Medicine (New York, NY, USA). "And even if it is not protective, it doesn't appear to be harmful so can probably be used safely to treat menopausal symptoms. There does appear to be a window of opportunity for use of estrogen.”

"This is an important and meaningful analysis for women who can benefit from hormone replacement therapy,” said Richard Hellman, M.D., president of the AACE. "Since the WHI was published in 2002, there has been much debate over the risk to reward ratio with this treatment option. Patient safety must always be our primary objective. We can now say with good confidence that this therapy is very safe for women under 60, or who have recently experienced menopause”.

The AACE recommends that each patient be evaluated by her doctor for the severity of her symptoms, age, and specific risk factors that might impact the efficacy of HRT. Non-hormonal therapies should be offered to those women who decline hormonal therapy.


Related Links:
American Association of Clinical Endocrinologists

New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
New
Hypodermic Syringe
SurTract™ Safety Syringe
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.